This approach was recently used to increase presentations to GPs and referrals for chest X-rays, and led to a 27% increase in lung cancer diagnoses in intervention areas compared with controls, although this difference was not statistically significant.
As before, increased presentation to type B T cells was observed in the presence of all three stimuli (Fig. 2A), while presentation of peptide to the type A T cells (3A9) showed some reduction at higher peptide concentrations but was not grossly affected (Fig. 2B).
Increasing presentations to emergency departments have led to overcrowding, long waiting times and suboptimal health system performance.
On the other hand, when chemotherapy is administered, the increased tumor cell death will result in increased antigen presentation to T-lymphocytes, thus increased T-cell reactivity may occur, as discussed in a recent review.
During April-December 2011, LCH reported a 19.1% increase in presentation to GPs for bowel cancer symptoms, 9.3% for lung and 0.58% for breast.
As shown in Figure 4B, the increase in presentation to type B T cells induced by curdlan was significantly blocked by the anti-Dectin-1 Ab 2A11 (63% inhibition), laminarin (55% inhibition), and anti-Dectin-1 Ab and laminarin in combination (66% inhibition).
We found that coupling of an HS ligand to the antigen increases antigen presentation to CD4+ and CD8+ T-cells after antigen targeting to membrane immunoglobulins or to MHC-II molecules.
IFN-γ increases antigen presentation to lymphocytes via induction of HLA-DR expression on monocytes.
The awareness campaign is designed to increase presentation rates for symptoms associated with CRC, which may result in the earlier diagnosis of other lower GI conditions such as Crohns disease, ulcerative colitis, inflammatory bowel disease, and piles.
We then increased rate of presentation to examine whether animals would habituate.
